George Simeon Insider Trades

Insider Trading History

Track insider trading activity for George Simeon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $90.1M 1,730,179 shares
Last Trade
Jul 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$51.5M 989,812 shares
$52.03
$52.08
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $198k 19,000 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.2k 19,000 shares
$4.01
$10.44
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $677k 13,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$501k 13,000 shares
$38.57
$52.08
Nkarta
Nkarta NKTX
Director
Holding Value $125k 46,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.2k 46,000 shares
$1.83
$2.72
Nkarta
Nkarta NKTX
Director
Holding Value $61.2k 22,500 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 22,500 shares
$6.23
$2.72
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $198k 19,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 19,000 shares
$3.82
$10.44
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $677k 13,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$703k 13,000 shares
$54.06
$52.08
Nkarta
Nkarta NKTX
Director
Holding Value $4.21M 1,548,341 shares
Last Trade
Mar 27, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20M 2,000,000 shares
$10.00
$2.72
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $40.1M 769,196 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.5M 1,048,951 shares
$89.12
$52.08
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $677k 13,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$814k 13,000 shares
$62.59
$52.08
Nkarta
Nkarta NKTX
Director
Holding Value $61.2k 22,500 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 22,500 shares
$4.86
$2.72
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $157k 15,000 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.5k 15,000 shares
$5.63
$10.44
Design Therapeutics
Design Therapeutics DSGN
Director
Holding Value $68.1M 6,526,476 shares
Last Trade
Dec 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$326k 40,000 shares
$8.14
$10.44
Design Therapeutics
Design Therapeutics DSGN
Director
Holding Value $67.7M 6,486,476 shares
Last Trade
Dec 19, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.11M 360,000 shares
$8.63
$10.44
Design Therapeutics
Design Therapeutics DSGN
Director
Holding Value $64M 6,126,476 shares
Last Trade
Dec 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.14M 500,000 shares
$8.28
$10.44
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Director
Holding Value $0 0 shares
Last Trade
Aug 17, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$646k 8,500 shares
$76.01
$75.49
Design Therapeutics
Design Therapeutics DSGN
Director
Holding Value $157k 15,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 15,000 shares
$13.69
$10.44
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $625k 12,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$860k 12,000 shares
$71.70
$52.08
Nkarta
Nkarta NKTX
Director
Holding Value $43.5k 16,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 16,000 shares
$14.95
$2.72
Nkarta
Nkarta NKTX
Director
Holding Value $1.81M 666,667 shares
Last Trade
Apr 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12M 666,667 shares
$18.02
$2.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up